Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
5.39
+0.39 (7.80%)
At close: Aug 12, 2026, 4:00 PM EDT
5.44
+0.05 (0.93%)
After-hours: Aug 12, 2026, 6:21 PM EDT
Unicycive Therapeutics Market Cap
Unicycive Therapeutics has a market cap or net worth of $147.65 million as of August 12, 2026. Its market cap has increased by 191.28% in one year.
Market Cap
147.65M
Enterprise Value
86.89M
1-Year Change
191.28%
Ranking
Category
Stock Price
$5.39
ChartMarket Cap Chart
Since the IPO on July 13, 2021, Unicycive Therapeutics's market cap has increased from $66.49M to $147.65M, an increase of 122.06%. That is a compound annual growth rate of 16.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 147.65M | 19.07% |
| Dec 31, 2025 | 124.01M | 50.43% |
| Dec 31, 2024 | 82.44M | 173.36% |
| Dec 29, 2023 | 30.16M | 270.11% |
| Dec 30, 2022 | 8.15M | -73.58% |
| Dec 31, 2021 | 30.84M | -53.61% |
| Jul 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 151.66M |
| Canton Strategic Holdings | 146.53M |
| TuHURA Biosciences | 146.47M |
| Cibus | 145.03M |
| NRx Pharmaceuticals | 142.50M |
| Connect Biopharma Holdings | 141.04M |
| Equillium | 141.00M |
| Indaptus Therapeutics | 134.76M |